REG - Fortis Frontier PLC - Transaction in Own Shares, TVR & Corp Broker Appt

Fortis FrontierAnnouncement

09/02/2026 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260209:nRSI1469Sa&default-theme=true

RNS Number : 1469S  Fortis Frontier PLC  09 February 2026

 

Fortis Frontier PLC

("Fortis Frontier" or the "Company")

 

Transaction in Own Shares and Total Voting Rights

Appointment of Corporate Broker

 

Fortis Frontier PLC (AIM: FORF), an AIM Rule 15 cash shell (formerly
MyHealthChecked PLC), announces that on 6 February 2026, pursuant to the
authority approved by shareholders at the Company's Annual General Meeting of
31 July 2025, the Company purchased 85,000 ordinary shares of 1.5 pence each
("Ordinary Shares") at a price of 8.0p per share, representing approximately
0.16% of the Company's issued share capital.

 

Total Voting Rights

The Company intends that the purchased Ordinary Shares will be cancelled in
due course. Following cancellation of the purchased Ordinary Shares, the
Company's total number of Ordinary Shares in issue shall be 51,600,827
Ordinary Shares.

 

The above figure of 51,600,827 Ordinary Shares may be used by shareholders as
the denominator for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest in, the
Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The Company also announces the appointment of Singer Capital Markets as the
Company's Corporate Broker with immediate effect following the transfer of
Dowgate Capital's corporate broking, advisory and research team to Singer
Capital Markets. Spark Advisory remains as the Company's Nominated Adviser.

 

 

For further information contact:

 

 Fortis Frontier PLC                                              www.fortisfrontierplc-ir.com (http://www.fortisfrontierplc-ir.com)
 Adam Reynolds, Executive Chairman                                via Walbrook PR

 SPARK Advisory Partners Limited (NOMAD)                          Tel: +44 (0)20 3368 3550
 Neil Baldwin / Dillon Wall

 Singer Capital Markets (Broker)                                  Tel: +44 (0)20 7496 3000
 James Serjeant / Russell Cook / Amber Higgs

 Walbrook PR Ltd (Media & IR)      Tel: +44 (0)20 7933 8780 or fortisfrontier@walbrookpr.com
                                   (mailto:fortisfrontier@walbrookpr.com)
 Paul McManus / Alice Woodings                                    Mob: +44 (0)7980 541 893 / +44(0)7407 804 654

 

 

About Fortis Frontier PLC

On 10 November 2025 MyHealthChecked PLC completed the disposal of its trading
subsidiary, Concepta Diagnostics Limited, becoming an AIM Rule 15 Cash Shell,
as defined in the AIM Rules for Companies. On the same day the Company changed
its name to Fortis Frontier PLC. The Board is now carefully considering the
strategic options available to it in order to maximise shareholder value.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCEAXAPEFNKEFA



            Copyright 2019 Regulatory News Service, all rights reserved